These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31559380)

  • 1. Portal-Mesenteric Vein Resection in Borderline Pancreatic Cancer; 33 Month-Survival in Patients with Good Performance Status.
    Tsiotos GG; Ballian N; Michelakos T; Milas F; Ziogou P; Papaioannou D; Salla C; Athanasiadis I; Razis E; Stavridi F; Psomas M
    J Pancreat Cancer; 2019; 5(1):43-50. PubMed ID: 31559380
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal-mesenteric vein resection for pancreatic cancer: Results in par with the defined benchmark outcomes.
    Tsiotos GG; Ballian N; Milas F; Ziogou P; Papaioannou D; Salla C; Athanasiadis I; Stavridi F; Strimpakos A; Psomas M; Kostopanagiotou G
    Front Surg; 2022; 9():1069802. PubMed ID: 36704507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
    J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
    Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
    J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection.
    Flis V; Potrc S; Kobilica N; Ivanecz A
    Radiol Oncol; 2016 Sep; 50(3):321-8. PubMed ID: 27679549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion].
    Kriger AG; Karmazanovsky GG; Smirnov AV; Kharazov AF; Gorin DS; Raevskaya MB; Galkin GV; Revishvili AS
    Khirurgiia (Mosk); 2018; (12):21-29. PubMed ID: 30560841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.
    Ravikumar R; Sabin C; Abu Hilal M; Bramhall S; White S; Wigmore S; Imber CJ; Fusai G;
    J Am Coll Surg; 2014 Mar; 218(3):401-11. PubMed ID: 24484730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
    Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
    J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
    Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
    J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
    Wang G; Zhou D
    Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer.
    Janssen QP; O'Reilly EM; van Eijck CHJ; Groot Koerkamp B
    Front Oncol; 2020; 10():41. PubMed ID: 32083002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
    Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
    Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
    Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
    Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
    Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study.
    Kurahara H; Shinchi H; Ohtsuka T; Miyasaka Y; Matsunaga T; Noshiro H; Adachi T; Eguchi S; Imamura N; Nanashima A; Sakamoto K; Nagano H; Ohta M; Inomata M; Chikamoto A; Baba H; Watanabe Y; Nishihara K; Yasunaga M; Okuda K; Natsugoe S; Nakamura M
    Langenbecks Arch Surg; 2019 Mar; 404(2):167-174. PubMed ID: 30649607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.